Cook Medical announced that the Zenith Alpha 2 (ZTA2) thoracic endovascular graft is commercially available in the United ...
A team of researchers at Cornell University has developed a new biodegradable vascular graft that could transform the treatment of cardiovascular disease, the leading cause of death worldwide.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback